Abstract Acne vulgaris (acne) is a chronic inflammatory disease prevalent among adolescents and adults, with significant psychological effects. The aetiology of acne is multifactorial. Several pathophysiological associations have been identified in which Propionibacterium acnes plays a major role. This bacteria primarily affects areas containing oil glands including the face, back and trunk, where it causes the formation of seborrhoea and inflammatory lesions. The treatment methods currently in place have side effects. A novel alternative method with no side effects is hence required. In this study, we report the synthesis of an exopolysaccharide (EPS)-producing bacterial-based nanoparticle as a stable biocompatible material for drug delivery. We then evaluated the effectiveness of EPS-based nanoparticle cream against P. acnes. Our results demonstrate that EPS nanoparticles have great potential as a safe and effective topical treatment for acne vulgaris and other associated infections.
nanoparticles       0.9999999999998863^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanoparticle          

side effects                  0.9999673899260482^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

chronic                       0.9999998435104211^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Chronic_(medicine)    

trunk                         0.9999188880487926^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Trunk_(anatomy)       

side effects                  0.9999673899260482^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adverse_effect        

inflammatory                  0.9999999999770353^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Inflammation          

nanoparticle                  0.9999999999414513^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanoparticle          

infections                    0.9977857871895822^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Infection             

EPS                           0.770767214423883^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Polystyrene           

EPS                           0.770767214423883^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Polystyrene           

nanoparticle                  0.9999999999414513^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanoparticle          

topical treatment             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Topical_medication    

Propionibacterium acnes       1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Propionibacterium_acnes

Acne vulgaris                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acne_vulgaris         

stable                        0.8841142953889981^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Stable_isotope        

inflammatory                  0.9999999999770353^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Inflammation          

bacteria                      0.9999999999994316^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Bacteria              

adolescents                   0.9999999999646434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Adolescence           

glands                        0.968659517005457^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Lymph_node            

acne vulgaris                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acne_vulgaris         

disease                       0.9999997017679779^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Disease               

aetiology                     0.9999999986235935^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Etiology              

drug delivery                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_delivery         

exopolysaccharide             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Exopolysaccharide     

acne                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acne_vulgaris         

seborrhoea                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Sebaceous_gland       

multifactorial                0.9999999129188419^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Quantitative_trait_locus

lesions                       0.9999996758162367^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Lesion                

biocompatible                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biocompatibility      

cream                         0.9999999998772182^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Cream_(pharmaceutical)

pathophysiological            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pathophysiology       

acne                          1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Acne_vulgaris         

